middle.news
Vitrafy Life Sciences Posts $25.7M Loss Amid $35M IPO Boost
5:29pm on Sunday 1st of June, 2025 AEST
•
Healthcare
Read Story
Vitrafy Life Sciences Posts $25.7M Loss Amid $35M IPO Boost
5:29pm on Sunday 1st of June, 2025 AEST
Key Points
Half-year loss surged 54,886% to $25.7 million
Completed $35 million IPO in November 2024
Advancing cryopreservation tech in animal and human health
Commercial contracts secured with Huon Aquaculture and Select Sires
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Vitrafy Life Sciences (ASX:VFY)
OPEN ARTICLE